Clinical Trial Update: Assessment of Compliance With Antihypertensive Telmisartan Therapy

View source ↗

Summary

This clinical trial update discusses patient compliance with telmisartan therapy for hypertension. The study, sponsored by Bayer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Micardis (telmisartan)

Snippet

Sponsor: Bayer | Conditions: Hypertension | Status: COMPLETED